Our journals hightlight outstanding science and brilliant scientists
- Three world-class journals, see below.
- 100% Open Access (CC BY 4.0). Authors keep copyright, may deposit in repositories.
- Quality & Integrity: Rigorous peer review and routine plagiarism screening
- Broad Scope Beyond Genomics. We welcome and publish innovation in multiple areas.
- Challenging Dogma. We welcome work that redefines thinking.
- World-Class Editorial Boards—National Academy members and a Nobel laureate.
- Science AND Scientists: Publishing breakthroughs and highlighting brilliant minds.
- 100+ scientists featured in our Genomic Press Interview, Innovators & Ideas section.
- Truly worldwide—4,000+ media outlets, 35+ languages, 2M+ social media views.
- Global reach. We process each manuscript based exclusively on its content, not where it comes from.
Brain Medicine: From Neurons to Behavior and Better Health is breaking new ground. By publishing the full continuum from pathophysiology to real-world effectiveness, Brain Medicine delivers what fragmented specialty journals cannot: a comprehensive, actionable understanding of brain health that transforms research into tangible improvements in human lives.To know more, please go to the journal’s website.
Genomic Psychiatry: Advancing Science from Genes to Society represents a paradigm shift in genetics journals by interweaving advances in genomics and genetics with progress in all other areas of contemporary psychiatry. We publish papers of the highest quality from any area within the continuum that goes from genes and molecules to neuroscience, clinical psychiatry, and public health. For details, please visit the journal’s website.
Psychedelics: The Journal of Psychedelic and Psychoactive Drug Research publishes side by side premier papers in psychedelics along with outstanding contributions in other psychoactive substances. This includes all compounds that affect consciousness and cognition, ranging from psychedelics to the full spectrum of psychoactive substances including stimulants (cocaine), cannabinoids (marijuana), entactogens (MDMA), dissociatives (ketamine), plant-derived substances (kavain), and novel compounds including drug discovery approaches.
As part of our commitment to excellence, we provide detailed and comprehensive guidelines across all our journals. Whether you are submitting research articles, reviews (including systematic reviews), commentaries, news & views, correspondence, or other manuscript types, our unified Author Instructions offer invaluable support. By streamlining the submission process, we make it more user-friendly. Join us in advancing scientific knowledge and shaping the future of research. For further details, please go to Author Instructions.
All our submissions undergo rapid and fair peer review.
Our Open Access model ensures that the vital insights you uncover are made widely available, breaking down barriers in knowledge exchange and maximizing the impact of your work.
Please stay tuned and visit each journal’s dedicated webpage through the links below for further updates.
At Genomic Press, we are proud to share our platforms for scientific dialogue and discovery. Join us on this exciting journey, charting new territories in genomic psychiatry and psychedelic and psychoactive drug research.
Welcome to a new era in scientific publishing!
